First-In-Human Phase I Trial of Ningetinib ( CT053PTSA ) in the Patients With Advanced Solid Tumors
Clinical trial NCT04577703 · COMPLETED
Trial details
- NCT number
- NCT04577703
- Sponsor
- Sunshine Lake Pharma Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2014-02-08
- Primary completion
- 2015-12-10
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.